Annual CFI
$0.00
+$29.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, APVO annual cash flow from investing activities is $0.00, with the most recent change of +$29.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, APVO annual CFI has fallen by -$28.03 million (-100.00%).
- APVO annual CFI is now -100.00% below its all-time high of $72.80 million, reached on December 31, 2018.
Performance
APVO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, APVO quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, APVO quarterly CFI has stayed the same.
- APVO quarterly CFI is now -100.00% below its all-time high of $65.36 million, reached on September 30, 2017.
Performance
APVO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, APVO TTM cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, APVO TTM CFI has stayed the same.
- APVO TTM CFI is now -100.00% below its all-time high of $87.64 million, reached on September 30, 2017.
Performance
APVO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
APVO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | 0.0% |
| 3 y3 years | -100.0% | 0.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% | -100.0% |
APVO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +100.0% | at high | +100.0% | at high | +100.0% |
| 5 y | 5-year | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Aptevo Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2023 | - | $0.00(0.0%) | -$4000.00(-86.2%) |
| Mar 2023 | - | $0.00(0.0%) | -$29.00 K(0.0%) |
| Dec 2022 | -$29.00 K(-95.9%) | $0.00(-100.0%) | -$29.00 K(-80.3%) |
| Sep 2022 | - | -$4000.00(-84.0%) | -$147.00 K(-5.8%) |
| Jun 2022 | - | -$25.00 K(<-9900.0%) | -$156.00 K(-70.1%) |
| Mar 2022 | - | $0.00(-100.0%) | -$522.00 K(-26.8%) |
| Dec 2021 | -$713.00 K(-102.5%) | -$118.00 K(+807.7%) | -$713.00 K(+4.4%) |
| Sep 2021 | - | -$13.00 K(-96.7%) | -$683.00 K(+1.9%) |
| Jun 2021 | - | -$391.00 K(+104.7%) | -$670.00 K(+140.1%) |
| Mar 2021 | - | -$191.00 K(+117.0%) | -$279.00 K(-101.0%) |
| Dec 2020 | $28.03 M(+584.2%) | -$88.00 K(<-9900.0%) | $28.03 M(-0.3%) |
| Sep 2020 | - | $0.00(0.0%) | $28.12 M(-13.1%) |
| Jun 2020 | - | $0.00(-100.0%) | $32.37 M(0.0%) |
| Mar 2020 | - | $28.12 M(>+9900.0%) | $32.37 M(+690.1%) |
| Dec 2019 | $4.10 M | $0.00(-100.0%) | $4.10 M(-68.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $4.25 M(>+9900.0%) | $13.14 M(-64.3%) |
| Jun 2019 | - | $0.00(-100.0%) | $36.84 M(-25.0%) |
| Mar 2019 | - | -$153.00 K(-101.7%) | $49.13 M(-32.5%) |
| Dec 2018 | $72.80 M(+147.1%) | $9.04 M(-67.7%) | $72.80 M(+634.2%) |
| Sep 2018 | - | $27.95 M(+127.3%) | $9.91 M(-79.0%) |
| Jun 2018 | - | $12.29 M(-47.7%) | $47.33 M(-15.2%) |
| Mar 2018 | - | $23.51 M(-143.7%) | $55.80 M(+89.4%) |
| Dec 2017 | $29.46 M(-162.2%) | -$53.84 M(-182.4%) | $29.46 M(-66.4%) |
| Sep 2017 | - | $65.36 M(+214.7%) | $87.64 M(-419.0%) |
| Jun 2017 | - | $20.77 M(-833.9%) | -$27.48 M(-44.1%) |
| Mar 2017 | - | -$2.83 M(-165.2%) | -$49.15 M(+3.7%) |
| Dec 2016 | -$47.39 M(+3003.7%) | $4.34 M(-108.7%) | -$47.39 M(-9.3%) |
| Sep 2016 | - | -$49.76 M(+5379.7%) | -$52.25 M(+1682.1%) |
| Jun 2016 | - | -$908.00 K(-15.2%) | -$2.93 M(+19.3%) |
| Mar 2016 | - | -$1.07 M(+108.0%) | -$2.46 M(+60.9%) |
| Dec 2015 | -$1.53 M(-96.9%) | -$515.00 K(+17.6%) | -$1.53 M(+50.9%) |
| Sep 2015 | - | -$438.00 K(+1.2%) | -$1.01 M(+76.3%) |
| Jun 2015 | - | -$433.00 K(+207.1%) | -$574.00 K(+307.1%) |
| Mar 2015 | - | -$141.00 K | -$141.00 K |
| Dec 2014 | -$48.80 M(+4679.6%) | - | - |
| Dec 2013 | -$1.02 M | - | - |
FAQ
- What is Aptevo Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual CFI year-on-year change?
- What is Aptevo Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly CFI year-on-year change?
- What is Aptevo Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Aptevo Therapeutics?
- What is Aptevo Therapeutics TTM CFI year-on-year change?
What is Aptevo Therapeutics annual cash flow from investing activities?
The current annual CFI of APVO is $0.00
What is the all time high annual CFI for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual cash flow from investing activities is $72.80 M
What is Aptevo Therapeutics annual CFI year-on-year change?
Over the past year, APVO annual cash flow from investing activities has changed by +$29.00 K (+100.00%)
What is Aptevo Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of APVO is $0.00
What is the all time high quarterly CFI for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly cash flow from investing activities is $65.36 M
What is Aptevo Therapeutics quarterly CFI year-on-year change?
Over the past year, APVO quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Aptevo Therapeutics TTM cash flow from investing activities?
The current TTM CFI of APVO is $0.00
What is the all time high TTM CFI for Aptevo Therapeutics?
Aptevo Therapeutics all-time high TTM cash flow from investing activities is $87.64 M
What is Aptevo Therapeutics TTM CFI year-on-year change?
Over the past year, APVO TTM cash flow from investing activities has changed by $0.00 (0.00%)